The global balloon catheter demand is subjected to growth at a CAGR of 4.3%. The market revenue is likely to be valued at USD 4.2 Billion in 2023 and exhibit a revenue growth of USD 6.4 Billion by 2033.
Key players aim at providing balloon catheter technologies that offer the excellent performance required to succeed in difficult circumstances. Furthermore, their exclusive laser-bonded method produces an exceptional TrakTipTM design as well as accurate, smooth bonding along the shaft. These also provide occlusion balloon catheters, which are particularly intended to minimize stone fragment movement down the ureter during PCNL treatments.
Mustang, created by a specific market player, improves patient outcomes because of its reduced sheath diameters. Mustang is meant to facilitate and speed up the operation by having superior cross and track, forceful dilatation, and longer lengths.
To ease strictures and allow the implantation of bigger surgical tools, consumers may always employ a balloon dilatation catheter developed for radial dilatation of the urinary tract. Furthermore, when reaching distant lesions in tiny veins below the knee, end users prefer PTA quick exchange balloon dilatation catheter.
Clinicians may also use the chameleon balloon catheter, which combines the functions of a high-pressure balloon catheter with a diagnostic catheter - allowing for the proximal administration of diagnostic fluids (such as contrast media) and therapeutic fluids. Key companies provide a comprehensive coronary portfolio that includes effective lesion preparation and treatment options. Their next-generation stents and balloon catheters enable polymer-free medication delivery for better clinical outcomes.
Over the previous 12 years, the product family presented by the majority of market participants has proven its functionality and efficacy for coronary lesion treatment, as evidenced by a substantial clinical evidence portfolio comprising more than 110 published studies. A market player recently introduced a next-generation balloon dilatation catheter with high-pressure capacity. It is intended to improve the treatment of patients with coronary artery disease (CAD) during angioplasty treatments.
The product is presently accessible in the United States, Europe, and a few Asian and Latin American countries. The novel method is suitable for both pre-and post-dilatation treatments. VOYAGER NC can be used by physicians to negotiate convoluted anatomy and open up lesions before delivering a stent, or to expand a stent more precisely against the arterial wall once it has been implanted.
Balloon catheters introduced by the key players are designed for stent post- and pre-dilatation of refractory lesions. They also have limited compliance and longitudinal balloon expansion. It is solely employed to dilate the stenotic segment of a coronary artery with a balloon. Moreover, it may be used to bypass graft stenosis to improve myocardial perfusion and for post-dilatation of coronary stents.
Some key players have been successful in domestically producing an IABP (Intra-Aortic Balloon Pumping) balloon catheter, a first-aid device for myocardial infarction. They continue to outperform their competitors in the high-tech medical industry.
| Attributes | Details |
|---|---|
| Balloon Catheter Market HCAGR (2017 to 2022) | 3.6% |
| Balloon Catheter Market CAGR (2023 to 2033) | 4.3% |
| Market Size for Balloon Catheter (2023) | USD 4.2 Billion |
| Market Size for Balloon Catheter (2033) | USD 6.4 Billion |
According to the World Health Organization (WHO) (2021), cardiovascular disease (CVD) is the leading cause of mortality globally, accounting for an estimated 17.9 Million deaths per year. Similarly, rising demand for minimally invasive operations, as well as an increase in the number of catheterization labs across the area, are likely to drive profitable growth during the projection period.
The majority of cardiovascular problems are treated with treatments such as percutaneous transluminal coronary angioplasty (PTCA), which makes heavy use of PTCA balloon catheters. As a result of the rising frequency of cardiovascular illnesses, a greater number of PCI operations are predicted to be performed. This is expected to create new balloon catheter market trends.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to the data compiled by Future Market Insights, the global forum of balloon catheters has experienced an exceptional growth in recent years. The market's leading providers are working in tandem with the growing demand for balloon catheters. The CAGR rate from 2017 to 2022 was 3.6%, and it is expected to increase to 4.3% during the forecast period.
By raw material type, the market is segmented into polyurethane, nylon, and others. The nylon sector is likely to have a large market share of 4.2% throughout the forecast period, according to Future Market Insights researchers.
The essential elements determining the velocity of this segment are:
Based on indication, the market is segmented into coronary artery disease and peripheral vascular disease. According to Future Market Insights analysts, the coronary artery disease sector is expected to have a larger market share throughout the forecast period and may require the most balloon catheters.
In the United States, balloon catheters are controlled by the Food and Drug Administration (FDA). The Food and Drug Administration and the United States agency in charge of medical device regulation give guidance on requirements for specific Class II applications. Consequently, the FDA's product recall is projected to hamper the market growth.
Principal Consultant
| Country | The United States |
|---|---|
| CAGR (2023 to 2033) | 4.2% |
| HCAGR (2017 to 2022) | 3.5% |
| Country | The United Kingdom |
|---|---|
| CAGR (2023 to 2033) | 4.8% |
| HCAGR (2017 to 2022) | 5.5% |
| Country | Germany |
|---|---|
| CAGR (2023 to 2033) | 4.7% |
| HCAGR (2017 to 2022) | 5.3% |
| Country | China |
|---|---|
| CAGR (2023 to 2033) | 4.8% |
| HCAGR (2017 to 2022) | 4.2% |
| Country | India |
|---|---|
| CAGR (2023 to 2033) | 5.6% |
| HCAGR (2017 to 2022) | 5.3% |
| Attributes | Details |
|---|---|
| USA Market Size (2033) | USD 1.6 Billion |
| USA Market Absolute Dollar Growth (USD Million/Billion) | USD 534.8 Million |
North America is a significant balloon catheter market, particularly in the USA, which holds a revenue share of 4.2%. The value of the balloon catheter market in the USA is estimated to reach a high of USD 1.6 Billion. This is attributed to the availability of modern healthcare facilities and infrastructure, healthcare spending, and increased patient awareness.
In the United States, consumers choose balloon catheters with low-profile cross-ability and proven clinical effectiveness in crossing stent struts and bifurcations. Furthermore, significant companies provide balloon catheters with innovative shaft and tip technology, as well as an extended-size matrix that improves the balance of trackability and pushability.
The key market driver is the number of percutaneous coronary intervention (PCI) operations since a slight drop in the average selling price of devices is projected.
| Attributes | Details |
|---|---|
| The United Kingdom Market Size (2033) | USD 273.4 Million |
| The United Kingdom Market Absolute Dollar Growth (USD Million/Billion) | USD 102.7 Million |
Diabetes prevalence, government efforts, and the release of various technologically improved products by key manufacturers are anticipated to propel the balloon catheter market share in Europe, especially in the United Kingdom and Germany. The United Kingdom produces notable market potential, with a high-paced revenue growth rate of 4.8% and an anticipated value of USD 273.4 Million, throughout the projection period.
The United Kingdom has a considerable global market share among world-leading providers of high-quality balloon catheters. Their balloon catheters are exceptional in terms of purity, symmetry, and robustness, which are critical for certain medical device applications. Key players in the United Kingdom provide a variety of balloon catheters particularly developed to stop severe posterior nasal bleeding (epistaxis) that cannot be stopped by conventional means.
They aspire to advance the area of stroke care via continual, deliberate innovation that yields real results. This is accomplished by focusing on the advancement of less invasive stroke therapeutics.
| Attributes | Details |
|---|---|
| Germany Market Size (2033) | USD 244.3 Million |
| Germany Market Absolute Dollar Growth (USD Million/Billion) | USD 89.8 Million |
Germany is a lucrative balloon catheter market, growing at a profit of 4.7%. The value of the balloon catheter market in Germany is expected to reach a high of USD 244.3 Million. Germany is home to the most recent generation of drug-eluting balloon technology, which is meant to provide the same level of safety and performance as the best-in-class DES technology.
The core products offered by the key clinicians include stents (balloon-expandable and self-expandable), balloons for coronary and peripheral applications, catheters, and a wide variety of interventional cardiology and radiology accessories. Moreover, they provide components for the medical industry, such as specific tubes and sticky adhesives. They also provide a product search service, which includes the procurement of specialty items.
Key companies provide equipment designed exclusively for use as a Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheter to dilate de novo or restenosis coronary lesions for improving myocardial perfusion and reducing the incidence of restenosis. Furthermore, they provide the most comprehensive selection of PTCA drug-eluting balloon catheters, with balloon diameters ranging from 1.50 mm to 5.00 mm and lengths ranging from 10 mm to 40 mm.
Most key companies establish customer value through their lean organizational structure as medium-sized businesses. As a consequence, response times are reduced, unique client demands are met, and costs are reduced. Hence, they provide German-quality items at extremely reasonable pricing. Their goal is to strengthen the long-term ties with their customers and increase long-term collaborations.
| Attributes | Details |
|---|---|
| China Market Size (2033) | USD 413.9 Million |
| China Market Absolute Dollar Growth (USD Million/Billion) | USD 154.6 Million |
China controls a sizable portion of the balloon catheter market, accounting for 4.8% of total sales. The balloon catheter market in China is expected to reach a peak of USD 413.9 Million. A few key players claim that the original members of their team are seasoned field professionals from China and the United States.
Their current core teams reputedly have more than a decade of field experience. Key players provide balloon catheters that combine their balloon tubing with 'Earnan Balloon Technology,' which is widely known for innovation and advanced technological solutions. They have pioneered additive manufacturing methods, employing unique techniques and medical-grade materials to produce components with complicated tolerances, geometries, and features.
tart-up companies have introduced advanced technologies to supply premium balloon catheters. This is expected to contribute to the global balloon catheter market growth:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The presence of a significant number of prominent players in various regions contributes to the market growth hugely. Ongoing Research and Development (R&D) operations to develop improved technologies, as well as new product innovation provide more potential for the balloon catheter market share.
Novel Developments:
The market is valued at USD 4.2 billion in 2023.
The market is estimated to record a CAGR of 4.3% through 2033.
Boston Scientific Inc., Medtronic, and Terumo Corporation are the key market players.
The rise in the number of angioplasty patients is to boost the market prospects.
The nylon segment is likely to remain preferred through 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033 5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 5.1. Normal Balloon Catheter 5.2. Cutting Balloon Catheter 5.3. Scoring Balloon Catheter 5.4. Drug Eluting Balloon Catheter 5.5. Stent Graft Balloon Catheter 6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Raw Material 6.1. Polyurethane 6.2. Nylon 6.3. Others 7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication 7.1. Coronary Artery Disease 7.2. Peripheral Vascular Disease 8. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 8.1. Hospitals 8.1.1. Private Hospitals 8.1.2. Public Hospitals 8.2. Ambulatory Surgical Centers 8.3. Cardiac Catheterization Laboratories 9. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. Eastern Europe 9.4. Western Europe 9.5. Asia Pacific excluding Japan (APEJ) 9.6. Japan 9.7. MEA 10. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13. Western Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14. APEJ Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15. Japan Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 16. MEA Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 17. Key Countries Analysis 18. Market Structure Analysis 19. Competition Analysis 19.1. Boston Scientific Inc. 19.2. Medtronic 19.3. Terumo Corporation 19.4. B. Braun Melsungen AG 19.5. MicroPort Scientific Corporation 19.6. Jotech GmbH 19.7. QX Medical LLC 19.8. Meril Life Pvt. Ltd 19.9. Hexacath 19.10. Abbott Laboratories 19.11. Tokai Medical Products Inc 19.12. Biosensors International Ltd. 19.13. Cook Medical Inc. 19.14. Cardionovum GmbH. 19.15. Cordis Corporation 19.16. Biotronik 19.17. Nitinol Device & Components Inc. 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Balloon Catheter Market
